Oral bisphosphonate compliance and persistence: a matter of choice?

Author： Silverman S.   Schousboe J.   Gold D.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.22, Iss.1, 2011-01, pp. : 21-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

By Cramer Joyce A.   Amonkar Mayur M.   Hebborn Ansgar   Altman Roy  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1453-1460

Informa Healthcare

Access to resources Recommend Favorite

Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy

By Gold Deborah T.   Trinh Haian   Safi Wael  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1831-1839

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates

By Earnshaw S. R.   Graham C. N.   Ettinger B.   Amonkar M. M.   Lynch N. O.   Middelhoven H.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2517-2529

Informa Healthcare

Access to resources Recommend Favorite

An osteonecrosis model induced by oral bisphosphonate in ovariectomised rats

By  

ORAL DISEASES, Vol. 21, Iss. 8, 2015-11 ,pp. : 969-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey

By Carr A.   Thompson P.   Cooper C.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1638-1644

Springer Publishing Company

Access to resources Recommend Favorite